When Evidence-Based Medicine Isn't Enough

If you’ve traveled the landscape of modern medicine in search of answers to your chronic health challenges, you’ve likely encountered the profound influence of Evidence-Based Medicine (EBM). It’s an approach revered for its rigorous scientific style, and that esteem is understandable. We want evidence to support claims, especially when our health is at stake.

But here’s what might surprise you: EBM might not mean what you think it does. Or what you want it to.

The “evidence” in guideline-driven EBM is like following a precise recipe for baking a cake—one determined to be the “best chocolate cake for an eight-year-old’s birthday party.” In the controlled environment that confirmed this designation, the climate is always the same. You have one type of oven, identical pans, and every ingredient measured to the exact gram from the same source, with no substitutions allowed.

But if you’ve ever tried to bake a cake, you know what happens when you bake at high altitude, with a different oven, or with slight variations in ingredients. Even the type of flour can yield vastly different results. The strict recipe—while proven in one controlled setting—might not yield the same perfect cake in every kitchen.

You Are Not an Average

The story in healthcare is more complex than guideline-driven EBM suggests, especially for those living with chronic illness. EBM protocols are derived from averages and standard deviations. But you are not an average. You live a life full of color and complexity that extends far beyond what can be encapsulated by statistical data.

Here’s what’s concerning: the clinical trials that led to many accepted guidelines have predominantly included specific demographics—mostly white and male, between ages 18 and 65, within certain body composition ranges. This lack of diversity has profound implications. It means the “average” identified for prescribing your treatment might not represent the response of other racial groups, genders, ages, or body types.

That average may not include you.

Imagine Sarah, a 42-year-old graphic designer living with rheumatoid arthritis. She runs her own business from home, is married with two children, and navigates her passions for rowing and skiing alongside managing her condition. While EBM guidelines suggest a standard medication regimen for RA, Sarah’s journey is anything but standard.

Despite following these guidelines, Sarah continued struggling with flares during times of stress, seasonal changes, and forest fires. These flares weren’t adequately addressed by the “average” treatment plan, leaving Sarah disappointed with the limitations of evidence alone.

Personal Evidence: The Other Side of the Coin

In my years of clinical practice, I’ve learned that what I call personal evidence can be equally valuable to evidence derived from clinical trials. What may be statistically significant in a study can be personally insignificant—or even inappropriate—for you.

Consider Alex, a college student diagnosed with ADHD who started taking Adderall. Initially, she noticed significant improvement in concentration and academic performance. But over time, she experienced increased anxiety, sleep disturbances, appetite loss, and body image concerns that began to overshadow the benefits. These changes affected her participation in college sports, which was particularly concerning given her swimming scholarship requirements.

When Alex came to me, we shifted the conversation from what generally works to what would work for her. Her late nights, missed meals, and midnight snacking weren’t conducive to focus and attention. She struggled with bloating and asthma, and her frequent swimming exposed her to high chlorine levels. By addressing these aspects in a targeted, sustainable manner suited to her dorm lifestyle, we explored root causes, identified triggers, and initiated gradual changes.

This approach led to durable habits, significant health improvements, and heightened self-awareness—all essential for her academic and athletic commitments while setting her up for future success.

The Healing vs. Curing Distinction

Dr. Lissa Rankin speaks beautifully to this distinction: “While I believe you can cure yourself, one gigantic lesson I learned is that healing is not the same as curing. You can cure without healing, and you can heal without curing... curing means ‘eliminating all evidence of disease,’ while healing means ‘becoming whole.’”

In the EBM paradigm, guidelines focus on attempting to “cure.” The role of healing is beyond its scope. But chronic care requires something different from the predominantly evidence-based acute care model. Your sustained struggles require a personalized approach that accounts for your history, narrative, and personal evidence.

Beyond the Confines

The limitations of strict EBM adherence include time constraints that delay simple lifestyle interventions, cost considerations that limit access, potential for bias affecting diverse populations, conflicts of interest from industry funding, lack of diversity in clinical trials, and resistance to adopting innovative solutions.

When you recognize the actual constraints of the scientific “rigor” promised by EBM, you open the door to a broader, more inclusive understanding of your health. You welcome a spectrum of evidence—from the empirical to the personal. You can blend the precision of EBM with the subjective truths of your own experience, crafting a healthcare journey that is uniquely yours.

This approach promotes a care model that truly caters to you, the person—not just you, the patient.

The complete exploration of personal evidence, including frameworks for reading your own narrative and bridging the gap between population data and individual experience, plus detailed case studies and practical applications, is in my full essay: Read: “Beyond the Evidence of Evidence-Based Medicine”